LYZA is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Afaxys Pharma Llc. The primary component is Norethindrone.
Product ID | 50102-100_230b1884-dd75-444c-a430-624a863a5195 |
NDC | 50102-100 |
Product Type | Human Prescription Drug |
Proprietary Name | LYZA |
Generic Name | Norethindrone |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2013-06-24 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA200980 |
Labeler Name | Afaxys Pharma LLC |
Substance Name | NORETHINDRONE |
Active Ingredient Strength | 0 mg/1 |
Pharm Classes | Progesterone Congeners [CS],Progestin [EPC] |
NDC Exclude Flag | E |
Listing Certified Through | 2018-12-31 |
Marketing Start Date | 2017-07-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA200980 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2013-06-24 |
Marketing End Date | 2013-07-17 |
Marketing Category | ANDA |
Application Number | ANDA200980 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2013-07-17 |
Marketing Category | ANDA |
Application Number | ANDA200980 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2013-07-17 |
Marketing Category | ANDA |
Application Number | ANDA200980 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2017-06-16 |
Marketing Category | ANDA |
Application Number | ANDA200980 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2017-07-01 |
Marketing Category | ANDA |
Application Number | ANDA200980 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2013-07-18 |
Ingredient | Strength |
---|---|
NORETHINDRONE | .35 mg/1 |
SPL SET ID: | fe2cb3eb-dcd0-470c-8cf0-78fda554b1f7 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
50102-100 | LYZA | norethindrone |
53002-1687 | LYZA | norethindrone |
51862-102 | Camila | Norethindrone |
51862-884 | CAMILA | NORETHINDRONE |
16714-440 | DEBLITANE | Norethindrone |
0555-0344 | Errin | Norethindrone |
51862-100 | Errin | Norethindrone |
51862-886 | ERRIN | NORETHINDRONE |
57297-877 | Jencycla | norethindrone |
52544-892 | Jolivette | NORETHINDRONE |
50102-300 | Lyleq | NORETHINDRONE |
53002-1793 | Lyleq | NORETHINDRONE |
52544-629 | Nora BE | Norethindrone |
0378-7272 | Norethindrone | Norethindrone |
0378-7292 | NORETHINDRONE | norethindrone |
50090-2150 | Norethindrone | Norethindrone |
50090-6161 | NORETHINDRONE | NORETHINDRONE |
57297-876 | NORETHINDRONE | NORETHINDRONE |
63187-748 | Norethindrone | Norethindrone |
42291-650 | Norethindrone Acetate | Norethindrone |
50268-602 | Norethindrone Acetate | Norethindrone |
50090-3235 | Norlyda | norethindrone |
51660-127 | NORLYROC | norethindrone |
50458-194 | Ortho Micronor | NORETHINDRONE |
16714-441 | SHAROBEL | Norethindrone |
50102-200 | Tulana | NORETHINDRONE |
53002-2687 | Tulana | NORETHINDRONE |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
LYZA 85879467 4523185 Live/Registered |
Afaxys, Inc. 2013-03-18 |
LYZA 77674711 not registered Dead/Abandoned |
Afaxys, Inc. 2009-02-20 |
LYZA 77296222 3644281 Dead/Cancelled |
EYERIS, INC. 2007-10-04 |